需要对疼痛医学中的丁丙诺啡进行进一步教育。

IF 2 Q3 PSYCHOLOGY, CLINICAL
Health Psychology Research Pub Date : 2023-05-24 eCollection Date: 2023-01-01 DOI:10.52965/001c.74958
Jamal Hasoon, Anvinh Nguyen, Ivan Urits, Christopher Robinson, Omar Viswanath, Alan D Kaye
{"title":"需要对疼痛医学中的丁丙诺啡进行进一步教育。","authors":"Jamal Hasoon, Anvinh Nguyen, Ivan Urits, Christopher Robinson, Omar Viswanath, Alan D Kaye","doi":"10.52965/001c.74958","DOIUrl":null,"url":null,"abstract":"<p><p>With the ongoing opioid epidemic in the United States there has been a strong transition towards utilizing multi-modal analgesia, interventional procedures, and non-opioid medications when managing acute and chronic pain. There has also been an increased interest in utilizing buprenorphine. Buprenorphine is a novel long-acting analgesic with partial mu-opioid agonist activity that can be utilized for analgesia as well as opioid use disorder. Buprenorphine also has a unique set of side effects as well pharmacodynamic and pharmacokinetic properties that require special attention, especially if these patients require future surgical interventions. Given the increased interest in this medication we believe that there needs to be increased education and awareness regarding this medication amongst physicians, specifically pain management physicians and trainees.</p>","PeriodicalId":51865,"journal":{"name":"Health Psychology Research","volume":"11 ","pages":"74958"},"PeriodicalIF":2.0000,"publicationDate":"2023-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317507/pdf/healthpsychologyresearch_2023_11_74958.pdf","citationCount":"0","resultStr":"{\"title\":\"A Need for Further Education on Buprenorphine in Pain Medicine.\",\"authors\":\"Jamal Hasoon, Anvinh Nguyen, Ivan Urits, Christopher Robinson, Omar Viswanath, Alan D Kaye\",\"doi\":\"10.52965/001c.74958\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>With the ongoing opioid epidemic in the United States there has been a strong transition towards utilizing multi-modal analgesia, interventional procedures, and non-opioid medications when managing acute and chronic pain. There has also been an increased interest in utilizing buprenorphine. Buprenorphine is a novel long-acting analgesic with partial mu-opioid agonist activity that can be utilized for analgesia as well as opioid use disorder. Buprenorphine also has a unique set of side effects as well pharmacodynamic and pharmacokinetic properties that require special attention, especially if these patients require future surgical interventions. Given the increased interest in this medication we believe that there needs to be increased education and awareness regarding this medication amongst physicians, specifically pain management physicians and trainees.</p>\",\"PeriodicalId\":51865,\"journal\":{\"name\":\"Health Psychology Research\",\"volume\":\"11 \",\"pages\":\"74958\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2023-05-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317507/pdf/healthpsychologyresearch_2023_11_74958.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Psychology Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52965/001c.74958\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"PSYCHOLOGY, CLINICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Psychology Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52965/001c.74958","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0

摘要

随着阿片类药物在美国的持续流行,在治疗急性和慢性疼痛时,已经向使用多模式镇痛、介入程序和非阿片类药的方向过渡。人们对丁丙诺啡的利用也越来越感兴趣。丁丙诺啡是一种具有部分μ阿片类激动剂活性的新型长效镇痛药,可用于镇痛和阿片类药物使用障碍。丁丙诺啡还有一系列独特的副作用以及需要特别关注的药效学和药代动力学特性,尤其是如果这些患者需要未来的手术干预。鉴于人们对这种药物越来越感兴趣,我们认为医生,特别是疼痛管理医生和受训人员,需要加强对这种药物的教育和认识。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Need for Further Education on Buprenorphine in Pain Medicine.

With the ongoing opioid epidemic in the United States there has been a strong transition towards utilizing multi-modal analgesia, interventional procedures, and non-opioid medications when managing acute and chronic pain. There has also been an increased interest in utilizing buprenorphine. Buprenorphine is a novel long-acting analgesic with partial mu-opioid agonist activity that can be utilized for analgesia as well as opioid use disorder. Buprenorphine also has a unique set of side effects as well pharmacodynamic and pharmacokinetic properties that require special attention, especially if these patients require future surgical interventions. Given the increased interest in this medication we believe that there needs to be increased education and awareness regarding this medication amongst physicians, specifically pain management physicians and trainees.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Health Psychology Research
Health Psychology Research PSYCHOLOGY, CLINICAL-
CiteScore
2.90
自引率
0.00%
发文量
63
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信